| scholarly article | Q13442814 |
| P2093 | author name string | Mahak Sharma | |
| Sanjay Kumar | |||
| Upender Manne | |||
| Rajesh Singh | |||
| Udai P Singh | |||
| Manoj K Mishra | |||
| Shalie Malik | |||
| Sanjeev Gurshaney | |||
| Erica Gage | |||
| Shezreen Qadri | |||
| Yori Adagunodo | |||
| P2860 | cites work | Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors | Q24310559 |
| FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha-mediated cytotoxicity | Q24535610 | ||
| Systems biology of cisplatin resistance: past, present and future | Q26863585 | ||
| Reconnoitring the status of prostate specific antigen and its role in women | Q26995569 | ||
| Novel adenosine-derived inhibitors of 70 kDa heat shock protein, discovered through structure-based design | Q27654001 | ||
| Three-dimensional structure of the ATPase fragment of a 70K heat-shock cognate protein | Q27667092 | ||
| Structural analysis of substrate binding by the molecular chaperone DnaK | Q27732810 | ||
| The human HSP70 family of chaperones: where do we stand? | Q28071416 | ||
| The role of heat shock protein 70 (Hsp70) in radiation-induced immunomodulation | Q28086922 | ||
| The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC | Q28210355 | ||
| Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression | Q28239558 | ||
| New insights into the mechanism of heat shock response activation | Q28266816 | ||
| The chaperone function of hsp70 is required for protection against stress-induced apoptosis | Q28679271 | ||
| Molecular chaperones in cellular protein folding | Q29547795 | ||
| Hsp70-Bag3 interactions regulate cancer-related signaling networks | Q30009385 | ||
| Mechanistic insights into the inhibition of prostate specific antigen by beta-lactam class compounds | Q33300264 | ||
| Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer | Q33471057 | ||
| Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone? | Q33550062 | ||
| Understanding PSA and its derivatives in prediction of tumor volume: Addressing health disparities in prostate cancer risk stratification | Q33591357 | ||
| Cis-acting elements involved in the regulated expression of a human HSP70 gene | Q34169016 | ||
| Biology of prostate-specific antigen | Q34170171 | ||
| Roles of the heat shock transcription factors in regulation of the heat shock response and beyond | Q34245695 | ||
| Hsp72 and stress kinase c-jun N-terminal kinase regulate the bid-dependent pathway in tumor necrosis factor-induced apoptosis | Q34279049 | ||
| Heat-shock proteins as regulators of apoptosis | Q34282224 | ||
| The resurgence of platinum-based cancer chemotherapy | Q34649255 | ||
| Structural optimization, biological evaluation, and application of peptidomimetic prostate specific antigen inhibitors | Q34732727 | ||
| Suppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-α gene therapy for pancreatic cancer | Q35051508 | ||
| A benzophenanthridine alkaloid, chelerythrine induces apoptosis in vitro in a Dalton's lymphoma | Q35092330 | ||
| Structure, function, and regulation of the enzyme activity of prostate-specific antigen | Q40386535 | ||
| Prostate-specific antigen (PSA): its clinical value in prostatic disease. | Q40396221 | ||
| Prostatic specific antigen | Q40398268 | ||
| Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate Cancer | Q42125180 | ||
| Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study. | Q43418836 | ||
| Plasma levels of heat shock protein 70 in patients with prostate cancer: a potential biomarker for prostate cancer | Q44997136 | ||
| Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer | Q47642158 | ||
| Novel Improved Synthesis of HSP70 Inhibitor, Pifithrin-μ. In Vitro Synergy Quantification of Pifithrin-μ Combined with Pt Drugs in Prostate and Colorectal Cancer Cells. | Q50222999 | ||
| The efficacy and safety of docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration: JMTO Pca 10-01 phase II trial. | Q50978342 | ||
| Intratumoral IL-12 and TNF-alpha-loaded microspheres lead to regression of breast cancer and systemic antitumor immunity. | Q51715108 | ||
| Biology of prostate-specific antigen | Q54246478 | ||
| Molecular chaperones in cellular protein folding: the birth of a field. | Q54291263 | ||
| Associations of lower urinary tract symptoms with prostate-specific antigen levels, and screen-detected localized and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatm | Q58856159 | ||
| Identifiable semen donors--attitudes of donors and recipient couples | Q68062235 | ||
| Teratomorphism in the urinary tract of MZ twins: short case report | Q68715677 | ||
| [Determination of tumor marker doubling time in the patients with prostate cancer relapsed from endocrine therapy] | Q72084416 | ||
| Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion | Q77555157 | ||
| High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways | Q79856384 | ||
| The effective management of biochemical recurrence in patients with prostate cancer | Q80297374 | ||
| Enhanced expression of the secreted form of clusterin following neoadjuvant hormonal therapy as a prognostic predictor in patients undergoing radical prostatectomy for prostate cancer | Q81323745 | ||
| Crosstalk between p53 and nuclear factor-B systems: pro- and anti-apoptotic functions of NF-B | Q82203467 | ||
| Enhanced expression of heat shock protein 27 following neoadjuvant hormonal therapy is associated with poor clinical outcome in patients undergoing radical prostatectomy for prostate cancer | Q83164555 | ||
| Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer | Q83164871 | ||
| Hsp70: anti-apoptotic and tumorigenic protein | Q84904226 | ||
| Clinical decision making in castration-resistant prostate cancer according to baseline prostate-specific antigen: are we measuring disease burden or disease biology? | Q85309005 | ||
| HSP70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells | Q35118904 | ||
| Prostate specific antigen gene regulation by androgen receptor | Q35887947 | ||
| Azapeptides as pharmacological agents | Q36074471 | ||
| Exogenous Hsp70 delays senescence and improves cognitive function in aging mice. | Q36435113 | ||
| Forkhead box M1 is regulated by heat shock factor 1 and promotes glioma cells survival under heat shock stress | Q36543725 | ||
| Tea and cancer prevention: molecular mechanisms and human relevance | Q36711773 | ||
| Causes of death in men with localized prostate cancer: a nationwide, population-based study | Q36799921 | ||
| Extracellular heat shock proteins in cell signaling | Q36820748 | ||
| The HSP70 family and cancer | Q36895403 | ||
| Discoveries and application of prostate-specific antigen, and some proposals to optimize prostate cancer screening | Q36907999 | ||
| Extracellular heat shock proteins in cell signaling and immunity | Q36989297 | ||
| The dual immunoregulatory roles of stress proteins. | Q37053268 | ||
| The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells. | Q37112632 | ||
| Similarity of the three-dimensional structures of actin and the ATPase fragment of a 70-kDa heat shock cognate protein | Q37529426 | ||
| Prostate-specific antigen: an overlooked candidate for the targeted treatment and selective imaging of prostate cancer | Q37697815 | ||
| Recent advances in cancer therapy: an overview. | Q37705530 | ||
| Azapeptides and their therapeutic potential. | Q37909404 | ||
| HSF1-mediated regulation of tumor cell apoptosis: a novel target for cancer therapeutics | Q38150878 | ||
| Hsp70 in cancer: back to the future | Q38263003 | ||
| Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line. | Q38327864 | ||
| Effects of cyclic heat stress or vitamin C supplementation during cyclic heat stress on HSP70, inflammatory cytokines, and the antioxidant defense system in Sprague Dawley rats | Q38457086 | ||
| Heat shock protein expression independently predicts clinical outcome in prostate cancer | Q38462724 | ||
| Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells. | Q38697766 | ||
| Targeting Hsp70: A possible therapy for cancer | Q38742944 | ||
| The hsp70 inhibitor VER155008 induces paraptosis requiring de novo protein synthesis in anaplastic thyroid carcinoma cells | Q38934843 | ||
| Activation of p53-dependent/-independent pathways of apoptotic cell death by chelerythrine in a murine T cell lymphoma | Q38948658 | ||
| VER-155008, a small molecule inhibitor of HSP70 with potent anti-cancer activity on lung cancer cell lines | Q39010794 | ||
| Pifithrin-μ, an inhibitor of heat-shock protein 70, can increase the antitumor effects of hyperthermia against human prostate cancer cells | Q39062053 | ||
| Chelerythrine induces reactive oxygen species-dependent mitochondrial apoptotic pathway in a murine T cell lymphoma | Q39117694 | ||
| The AKT/NF-κB inhibitor xanthohumol is a potent anti-lymphocytic leukemia drug overcoming chemoresistance and cell infiltration. | Q39374501 | ||
| A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling | Q39681312 | ||
| A small molecule inhibitor of inducible heat shock protein 70. | Q39789249 | ||
| Pifithrin-alpha decreases the radioprotective efficacy of a Podophyllum hexandrum Himalayan mayapple fraction REC-2006 in HepG2 cells. | Q39857996 | ||
| (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. | Q40230429 | ||
| Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation | Q40371434 | ||
| P304 | page(s) | 1987-2000 | |
| P577 | publication date | 2018-06-01 | |
| P1433 | published in | Frontiers in Bioscience | Q5506062 |
| P1476 | title | Hsp70 and gama-Semino protein as possible prognostic marker of prostate cancer. | |
| P478 | volume | 23 |
Search more.